Lifecore Biomedical to Join 43rd Annual J.P. Morgan Healthcare Conference

CHASKA, Minn., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR), known simply as Lifecore, is a fully integrated contract development and manufacturing organization (CDMO). The company has officially announced its participation in the upcoming 43rd Annual J.P. Morgan Healthcare Conference, which is scheduled to take place from January 13 to January 16, 2025, in San Francisco, California.

Conference Participation Details

Lifecore Biomedical will be represented by key management personnel at the conference. Notable figures such as Paul Josephs, the chief executive officer, and Ryan Lake, the chief financial officer, are expected to engage in one-on-one meetings with various attendees.

• Conference: 43^rd Annual J.P. Morgan Healthcare Conference
• Meeting Format: One-on-one meetings
• Conference Dates: January 13-16, 2025
• Location: San Francisco, California

Overview of Lifecore Biomedical

Lifecore Biomedical is a prominent CDMO that specializes in the development, production, and filling of sterile injectable pharmaceutical products. Their offerings include syringes, vials, and cartridges, and they are particularly known for handling complex formulations. With over 40 years of experience, Lifecore is a leading manufacturer of injectable-grade hyaluronic acid. The company collaborates with both established and emerging biopharmaceutical and biotechnology companies across various therapeutic areas to successfully bring new innovations to market.

For further details about Lifecore Biomedical and its services, interested parties can visit their official website at www.lifecore.com.

Lifecore, Healthcare, Conference